Biologic therapy of cancer /
Saved in:
| Edition: | 2nd ed. |
|---|---|
| Imprint: | Philadelphia : Lippincott, c1995. |
| Description: | xvii, 919 p. : ill. (some col.) ; 29 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/1694199 |
Table of Contents:
- Pt. 1. Principles of Biologic Therapy of Cancer. 1. Biology of Cellular Immune Responses / Nicholas P. Restifo and John R. Wunderlich. 2. Biology of Antibody-Mediated Responses / Sandra J. Smith-Gill. 3. Biology of Tumor Antigens. Sect. 3.1. Genes Coding for Tumor Antigens Recognized by T Lymphocytes / Yutaka Kawakami and Paul F. Robbins. Sect. 3.2. Tumor Antigens Recognized by Immune Cells / Walter J. Storkus and Michael T. Lotze. Sect. 3.3. Tumor Antigens Recognized by Monoclonal Antibodies / Soldano Ferrone, T. Ming Chu, Ingegerd Hellstrom and Karl E. Hellstrom. 4. Biology of Cytokines: The Interleukins / Robert J. Tushinski and James J. Mule. 5. Principles of Cell Killing by Biologic Agents / David M. Hockenbery. 6. Immunocompetence and Cancer / Israel Penn
- Pt. 2. Biologic Therapy of Cancer. 7. Colony-Stimulating Factors: Basic Principles and Preclinical Studies / Malcolm A. S. Moore. 8. Colony-Stimulating Factors: Clinical Applications. Sect. 8.1. Granulocyte-Stimulating Factors / Langdon L. Miller. Sect. 8.2. Platelet-Stimulating Factors / Jeffrey S. Weber and Michael S. Gordon. Sect. 8.3. Erythrocyte-Stimulating Factors / Robert T. Means, Jr. Sect. 8.4. Macrophage-Colony Stimulating Factor / David R. Parkinson. 9. Biologic Therapy with Interleukin-2: Preclinical Studies / Michael T. Lotze. 10. Biologic Therapy with Interleukin-2: Clinical Applications. Sect. 10.1. Principles of Administration and Management of Side Effects / Douglas J. Schwartzentruber. Sect. 10.2. Melanoma / Francesco M. Marincola and Steven A. Rosenberg. Sect. 10.3. Renal Cell Cancer / James C. Yang. Sect. 10.4. Other Cancers / Mario Sznol. 11. Role of IL-4, IL-6, and IL-12 in Cancer Therapy / Robert L. Truitt, Carolyn A. Keever and Ernest C. Borden. 12. Biologic Therapy with TNF: Preclinical Studies / Walter Fiers. 13. Biologic Therapy with TNF: Systemic Administration and Isolation-Perfusion / Douglas L. Fraker, H. Richard Alexander and Harvey I. Pass. 14. Biologic Therapy with Interferon-[alpha] and [beta]: Preclinical Studies / Thazepadath Sreevalsan. 15. Biologic Therapy with Interferon-[alpha] and [beta]: Clinical Applications. Sect. 15.1. Hairy Cell Leukemia, Chronic Myelogenous Leukemia, and Myeloproliferative Disorders / Kenneth A. Foon. Sect. 15.2. Renal Cell Cancer / Paul D. Savage and Hyman B. Muss. Sect. 15.3. Melanoma / John M. Kirkwood. Sect. 15.4. Kaposi's Sarcoma / Susan E. Krown. Sect. 15.5. Multiple Myeloma / Sydney E. Salmon. Sect. 15.6. Clinical Applications of Interferon in Other Tumors / William J. John and Kenneth A. Foon. 16. Biologic Therapy with Interferon-[gamma] / Jorge R. Quesada. 17. Combination Cytokine Therapy / Michael B. Atkins, Elizabeth G. Trehu and James W. Mier. 18. Cell Transfer Therapy: Preclinical Studies / Suzanne L. Topalian. 19. Cell Transfer Therapy: Clinical Applications / Steven A. Rosenberg. 20. Monoclonal Antibodies in Cancer Therapy. Sect. 20.1. Basic Principles / Jeffrey Schlom. Sect. 20.2. Immunotoxins and Recombinant Toxins / Lee H. Pai and Ira Pastan. Sect. 20.3. Radioisotope Conjugates / Steven M. Larson, George Sgouros and Nai-Kong V. Cheung. 21. Clinical Applications of Monoclonal Antibodies in Cancer. Sect. 21.1. B-Cell Lymphomas / Larry W. Kwak, Michael L. Grossbard and Walter J. Urba. Sect. 21.2. T-Cell Leukemia/Lymphoma / Thomas A. Waldmann. Sect. 21.3. Melanoma / Alan N. Houghton and Paul B. Chapman. Sect. 21.4. Adenocarcinomas / Ernest C. Borden and Tom Anderson. Sect. 21.5. Purging of Bone Marrow / John G. Gribben and Lee M. Nadler. Sect. 21.6. Antibodies to Growth Factors and Receptors / John Mendelsohn and Jose Baselga. 22. Cancer Vaccines: Preclinical Studies / Dorothee Herlyn, Lutz Jacob and Rajasekharan Somasundaram. 23. Cancer Vaccines: Clinical Applications. Sect. 23.1. Immune Adjuvants / Emmanuel T. Akporiaye and Evan M. Hersh. Sect. 23.2. Whole Cell Vaccines / Michael J. Mastrangelo, Henry C. Maguire, Jr., Edmund C. Lattime and David Berd. Sect. 23.3. Viral Oncolysates / Muthukumaran Sivanandham and Marc K. Wallack. Sect. 23.4. Partially Purified Tumor Antigen Vaccines / Jean-Claude Bystryn, Richard L. Shapiro and Ruth Oratz. Sect. 23.5. Immunization with Synthetic or Highly Purified Tumor Antigens / Philip Livingston. 24. Local Therapy with Biologic Agents. Sect. 24.1. Intralesional Therapy / Donald L. Morton and Andreas Barth. Sect. 24.2. Instillation Therapy for Bladder Cancer / Harry W. Herr. 25. Gene Therapy of Cancer. Sect. 25.1. Basic Principles and Safety Considerations / Paul Tolstoshev and W. French Anderson. Sect. 25.2. Gene Therapy Using Lymphocyte Modification / Patrick Hwu and Steven A. Rosenberg. Sect. 25.3. Gene Therapy Using Stem Cell Modification / Albert Deisseroth, Siqing Fu, Elie G. Hanania, Moshe Talpaz, Hagop Kantarjian and Richard Champlin. Sect. 25.4. Gene Therapy Using "Suicide" Genes / R. Michael Blaese. Sect. 25.5. Gene Therapy by Direct Gene Transfer / Gary J. Nabel and Elizabeth G. Nabel. Sect. 25.6. Antisense Oligodeoxynucleotides / Cy A. Stein. Sect. 25.7. Gene Modification of Tumors / Elizabeth M. Jaffee, Herb Hurwitz and Drew M. Pardoll
- Pt. 3. Other Approaches to Biologic Therapy. 26. Chemically Defined Immunomodulators and Interferon Inducers / Patricia L. Witt. 27. Levamisole / David R. Parkinson. 28. Differentiation Agents / Raymond P. Warrell, Jr. 29. Tamoxifen / John R. Benson, Michael Baum and Anthony A. Colletta. 30. Systemic Activation of Macrophages by Liposomes Containing Immunomodulators / Eugenie S. Kleinerman and Isaiah J. Fidler. 31. Thymosin / Karen Kashmanian Oates and Allan L. Goldstein. 32. Antimetastatic Therapy / Ronald H. Goldfarb and Kenneth W. Brunson. 33. Interaction of Biologic Agents with Chemotherapy / Jose Baselga and John Mendelsohn
- Pt. 4. Regulatory Issues Related to Biologic Agents. 34. Development of Biological Therapeutics for Oncologic Use / Jay P. Siegel, Theresa Gerrard, Joy A. Cavagnaro, Patricia Keegan, Roger B. Cohen and Kathryn Zoon.
